Figure 1

(A–C) Correlations of PIVKA-II, AFP, and the γ-GT/ALT ratio with tumour size. (D–F) Comparison of serum levels of PIVKA-II and AFP and the serum γ-GT/ALT ratio in patients with advanced HCC, early-stage HCC, and CHB.

(A–C) Correlations of PIVKA-II, AFP, and the γ-GT/ALT ratio with tumour size. (D–F) Comparison of serum levels of PIVKA-II and AFP and the serum γ-GT/ALT ratio in patients with advanced HCC, early-stage HCC, and CHB.